Dr Vigrosky is testing the effectiveness of a new drug, called Xiptoflux, which is
supposed to alleviate certain symptoms which accompany "restless leg syndrome.
" Dr
Vigrosky gives one group of participants, who suffer from "RLS," a drug which has
already been approved by the FDA. He gives another group of participants, who suffer
from "RLS," the new drug, Xiptoflux. He found no significant difference between the
new drug and the old drug in terms of the alleviation of the symptoms of "restless leg
syndrome." What aspect of Dr Vigrosky's design could be improved in subsequent trials
of the study?
A) He could have compared the two drugs to a third "restless leg syndrome" drug
B) He could have used an experimental group
C) He could have used a placebo control group
D) He could have given the new drug to a group of people who do not suffer from
"RLS"
C
You might also like to view...
A toddler who is securely attached will behave in what ways during the Strange Situation procedure?
The toddler usually cries upon separation but when the mother returns they greet her happily and begin to smile. The toddler shows little or no interaction when the mother is present and no response when she departs. The toddler is less likely than others to explore the room and shows greater-than-normal distress when she leaves. The toddler seems dazed and detached when the mother leaves the room and remains fearful upon her return.
Research with Asian Americans in treatment for schizophrenia indicates that clinicians might
increase the success of treatment with Caucasian patients if they ______. a. included family members in the therapy process b. lowered the dosages of antipsychotic drugs c. used a wider variety of alternative approaches to therapy d. treated patients with a greater degree of respect and equality